Hyperosmolar hyperglycemic state in advanced amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 4, 2011, Pages 309-311

  Shimizu, Toshio ^a,d   Honda, Masayuki ^a   Ohashi, Takuya ^b   Tsujino, Motoyoshi ^b   Nagaoka, Utako ^a   Kawata, Akihiro ^a   Watabe, Kazuhiko ^c   Matsubara, Shiro ^a   Hayashi, Hideaki ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b TOKYO METROPOLITAN TAMA MEDICAL CENTER   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d NONE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; hyperosmolar hyperglycemic state; insulin resistance; insulin secretion; totally locked in state

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DROWSINESS; FEEDING APPARATUS; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HUMAN; HYDRATION; HYPERGLYCEMIA; HYPEROSMOLARITY; INFECTION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; MEDICAL HISTORY; MUSCLE ATROPHY; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; POLYURIA; PRIORITY JOURNAL; QUADRIPLEGIA; THERAPY EFFECT; TREATMENT RESPONSE; DRUG EFFICACY; HYPEROSMOLAR HYPERGLYCEMIC STATE; PAROTITIS; PNEUMONIA; URINARY TRACT INFECTION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OSMOLAR CONCENTRATION;

EID: 80054020353     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2010.539234     Document Type: Article

References (12)

1. Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166-71.
2. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux- Burel H, Ferrier A, et al. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256: 1236-42.
3. Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004-9. (Pubitemid 351451324)
4. Hayashi H, Oppenheimer EA. ALS patients on TPPV: totally locked-in state, neurologic fi ndings and ethical implications. Neurology. 2003;61:135-7. (Pubitemid 36818767)
5. Shimizu T, Hayashi H, Kato S, Hayashi M, Tanabe H, Oda M. Circulatory collapse and sudden death in respiratordependent amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:45-55. (Pubitemid 24183993)
6. Shimizu T, Hayashi H, Tanabe H. Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Rinsho Shinkeigaku. 1991;31:255-9.
7. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95. (Pubitemid 38680001)
8. Kaji M, Nomura M, Tamura Y, Ito S. Relationships between insulin resistance, blood glucose levels and gastric motility: an electrogastrography and external ultrasonography study. J Med Invest. 2007;54:168-76. (Pubitemid 46769079)
9. Tanaka Y, Atsumi Y, Asahina T, Hosokawa K, Matsuoka K, Kinoshita J, et al. Usefulness of revised fasting plasma glucose criterion and characteristics of insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care. 1998;21:1133-7. (Pubitemid 28368521)
10. Kato S, Hayashi H, Yagishita A. Involvement of the frontotemporal lobe and limbic system in amyotrophic lateral sclerosis - as assessed by serial computed tomography and magnetic resonance imaging. J Neurol Sci. 1993;116:52-8. (Pubitemid 23144794)
11. Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65:636-41. (Pubitemid 351679659)
12. Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487-93. (Pubitemid 41476132)